CVS' third-quarter 2024 results reflect strong performance in the Health Services and Pharmacy & Consumer Wellness segments.

CVS also reported its quarterly results today, with revenue exceeding but earnings missing the street estimates.

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

The stock is down 22% year-to-date. Tesla rallies after Trump wins election. Tesla shares surged 15% after Donald Trump’s ...

CVS Health will report third-quarter earnings before the market opens Wednesday as the pharmacy and health-care provider ...

CVS Health rated Hold, offers dividend yield, facing challenges from CMS decisions and rising medical costs in healthcare ...

CVS Health has an analyst consensus of Moderate Buy, with a price target consensus of $68.15, implying a 26.13% upside from current levels. In a report released on November 11, TD Cowen also ...

Eva Marie Uzcategui / Bloomberg / Getty Images CVS Health reported better-than-expected quarterly results, and the new CEO ...

U.S. presidential election, Fed FOMC meeting, and more earnings will be in focus this week. Arista Networks is a buy with a ...